首页 | 本学科首页   官方微博 | 高级检索  
     


2-Mercaptoimidazoles, a new class of potent CCR2 antagonists
Authors:Van Lomen Guy  Doyon Julien  Coesemans Erwin  Boeckx Staf  Cools Marina  Buntinx Mieke  Hermans Bart  Van Wauwe Jean
Affiliation:Inflammation Research, Johnson and Johnson Pharmaceutical Research and Development, Beerse, Belgium. gvlommen@prdbe.jnj.com
Abstract:We describe the synthesis and SAR of a new class of CCR2 antagonists based on 2-mercaptoimidazole scaffold. The initial lead 1a was optimized to the 3,4-disubstituted analogues 1p-(S) and 1q-(S), which have IC(50) values in the MCP-1 induced Ca-flux below 0.01 microM.
Keywords:
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号